Emergency Medicine · Toxicology
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Classic triad is altered mental status, autonomic instability, and neuromuscular hyperactivity with pathognomonic clonus (greater in the lower extremities).
Caused by excess serotonergic activity, typically from combining SSRIs, MAOIs, TCAs, or illicit drugs.
Diagnose clinically using the //Hunter Toxicity Criteria//, requiring a serotonergic agent plus findings such as spontaneous clonus.
First step is immediate discontinuation of all serotonergic agents plus supportive care with benzodiazepines (lorazepam).
The first-line antidote for severe cases is cyproheptadine, a 5-HT2A antagonist.
Antipyretics are ineffective because hyperthermia is generated by muscle activity, not a hypothalamic set-point change.
Differentiate from NMS, which has lead-pipe rigidity, hyporeflexia, and slow onset over days versus the rapid clonus of serotonin syndrome.
Vignette unlocked
A 29-year-old woman taking fluoxetine is brought to the ED several hours after starting tramadol for back pain. She is agitated and diaphoretic with a temperature of 39.8°C, heart rate of 124/min, and blood pressure of 162/98 mm Hg. Exam reveals dilated pupils, hyperreflexia, and spontaneous clonus that is more pronounced in the lower extremities.
After discontinuing the offending agents and giving benzodiazepines, which of the following is the most appropriate antidote for this patient?
Cyproheptadine.
The triad of altered mental status, autonomic instability, and neuromuscular hyperactivity with lower-extremity clonus following addition of tramadol to an SSRI confirms serotonin syndrome by the Hunter criteria. Cyproheptadine, a 5-HT2A antagonist, is the first-line antidote for severe cases; antipyretics are useless because the hyperthermia arises from sustained muscle activity.
Full handout
High yield triage
Etiology / Epidemiology
Caused by life-threatening excess serotonergic activity in the CNS and PNS, typically from combining SSRIs, MAOIs, TCAs, or illicit drugs.
Clinical Manifestations
Presents with a classic triad of altered mental status, autonomic instability, and neuromuscular hyperactivity, classically exhibiting pathognomonic clonus.
Diagnosis
A clinical diagnosis utilizing the //Hunter Toxicity Criteria//, which requires the presence of a serotonergic agent plus specific findings like spontaneous clonus.
Treatment
Immediately discontinue offending agents, provide supportive care with benzodiazepines, and administer cyproheptadine for severe cases.
Prognosis
Most cases resolve within 24 hours of drug cessation, but untreated severe cases risk hyperthermia, rhabdomyolysis, and multisystem organ failure
Full handout
Epidemiology & Etiology
Often triggered by accidental drug interactions, intentional overdose, or starting a new medication without an adequate washout period, such as switching an SSRI to an MAOI without a 14-day gap. Common pharmacological culprits include SSRIs, SNRIs, MAOIs, TCAs, tramadol, linezolid, ondansetron, and illicit drugs like MDMA (ecstasy). Combining agents that inhibit serotonin reuptake, decrease its metabolism, or increase its synthesis drastically amplifies the risk of this life-threatening toxidrome.
Pertinent Anatomy
The syndrome involves the central nervous system, specifically the brainstem and hypothalamus, which mediate the profound mental status and autonomic changes. The peripheral nervous system and neuromuscular junction mediate the profound motor excitability, resulting in characteristic lower-extremity hyperreflexia.
Pathophysiology
The condition results from the life-threatening overactivation of central and peripheral 5-HT1A and 5-HT2A receptors. Excess serotonergic stimulation in the brainstem leads to profound autonomic hyperactivity and hyperthermia. Simultaneous overstimulation in the spinal cord and peripheral nerves causes severe neuromuscular excitability, manifesting as extreme hyperreflexia and continuous muscle contraction.
Clinical Manifestations
Patients present with a rapidly progressive classic triad: altered mental status (agitation, delirium), autonomic instability (tachycardia, diaphoresis, hyperthermia), and neuromuscular hyperactivity (tremor, hyperreflexia). A highly pathognomonic finding is inducible or spontaneous clonus, which is classically greater in the lower extremities. Red flag symptoms include temperatures >41.1°C (106°F) and severe muscle rigidity, which signal impending respiratory failure and rhabdomyolysis.
Diagnosis
This is primarily a clinical diagnosis, utilizing the //Hunter Toxicity Criteria// as the gold standard diagnostic tool. Diagnosis requires a documented history of serotonergic agent exposure plus specific physical findings, most notably spontaneous clonus, or inducible clonus with accompanying agitation or diaphoresis. Laboratory tests are non-diagnostic but are essential to rule out severe complications like rhabdomyolysis by checking for an elevated CK or impending renal failure.
Treatment
Immediate discontinuation of all serotonergic agents is the absolutely critical first step in management. Mild to moderate cases require supportive care with IV fluids and benzodiazepines (e.g., lorazepam) to control agitation, reduce heart rate, and decrease muscle contraction. For severe cases featuring profound hyperthermia and marked rigidity, the first-line antidote is cyproheptadine, a potent 5-HT2A antagonist. Antipyretics are ineffective and should not be used because the hyperthermia is generated by intense muscle activity, not a change in the hypothalamic temperature set-point.
Prognosis
The prognosis is generally excellent if recognized early, with the majority of symptoms resolving within 24 hours of discontinuing the offending drugs and initiating supportive therapy. However, unrecognized or untreated severe cases can rapidly progress to fatal hyperthermia, status epilepticus, rhabdomyolysis, and disseminated intravascular coagulation (DIC).
Differential Diagnosis
1. Neuroleptic Malignant Syndrome (NMS): Triggered by dopamine antagonists; classically presents with lead-pipe rigidity and hyporeflexia developing over days, unlike the clonus and rapid onset of serotonin syndrome.
2. Malignant Hyperthermia: Triggered by inhaled anesthetics or succinylcholine; presents with intense muscle rigidity and hyperthermia but lacks the hyperreflexia and clonus seen in serotonin syndrome.
3. Anticholinergic Toxicity: Presents with "blind as a bat, mad as a hatter" symptoms; features normal reflexes and significantly dry skin, differentiating it from the profound diaphoresis of serotonin syndrome.